Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03355287
Other study ID # Eth_Teff_Iron
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 2018
Est. completion date August 2019

Study information

Verified date September 2018
Source Swiss Federal Institute of Technology
Contact Colin Cercamondi, PhD
Phone +41 44 632 86 34
Email colin.cercamondi@hest.ethz.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the impact of soil iron intake from teff flour on iron status in infants in Debre Zeit, Ethiopia.


Description:

Rationale: Teff (Eragrostis Teff), a major staple crop in several areas of Ethiopia, is of special relevance to Fe biofortifcation as it provides the population with a regular high consumption of contaminant soil Fe due to the traditional threshing procedure under the hooves of the cattle. The bioavailability of soil Fe, and hence its contribution to Fe requirements, is unknown. Data on the bioavailability of soil Fe would clarify to what extent the soil Fe can be considered as a source of absorbable Fe. This information is important in order to establish dietary advice and is essential for the development of iron biofortification (and fortification) policies related to Fe nutrition in Ethiopia.

Objective: The overall objective of the project is to generate data to target and tailor biofortification approaches in Ethiopia by an intervention trial assessing the impact of soil Fe intake from teff consumption on Fe status.

Study design: The intervention trial will be a 7 months partially blinded, randomized control trial (RCT) with the following three arms: control-group consuming injera based on traditionally threshed teff (average Fe content 50 mg/100g flour), 2) intervention group consuming injera based on lab-threshed teff (average Fe content 6.65 mg/100g flour), 3) positive control group consuming the lab-threshed teff together with ferrous sulphate iron drops (additional Fe from the drops = 6 mg).

Study population: 315 children between 18-36 months of age living in Debre Zeit and surrounding areas will be enrolled.

Main study parameters/endpoints: The impact of soil Fe in teff on Fe status will be assessed by measuring the Fe status, prevalence of Fe deficiency and Fe deficiency anemia at baseline, midpoint and endpoint. To assess Fe status, Hemoglobin (Hb), Plasma Ferritin (PF), Soluble Transferrin Receptor (sTfR), C- Reactive Protein(CRP) and Alpha 1B glycoprotein (AGP) will be determined.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 315
Est. completion date August 2019
Est. primary completion date June 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Months to 36 Months
Eligibility Inclusion Criteria:

- 18-36 months of age (at screening)

- The child is able to eat at least two injera meals per day

- The informed consent form has been read and signed by the caregiver (or has been read out to the caregiver in case of illiteracy)

Exclusion Criteria:

- Severely deficient in Hb (<70g/L)

- Severe underweight (weight for age Z score < -3),

- Severe wasting (weight for height Z score < -3)

- Chronic or acute illness or other conditions that in the opinion of the Principle Investigator (PI) or co-researchers would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol

- Participants taking part in other studies requiring the drawing of blood

- Not planning long-term residence in study site

Study Design


Intervention

Other:
Traditionally Threshed Teff (TTT)
The intervention will take place for 7 months in Debre Zeit where the the arm will be fed injera based on teff that are threshed traditionally
Lab Threshed Teff (LTT)
The intervention will take place for 7 months in Debre Zeit where this arm will be fed injera from teff that is threshed using a modern thresher.
Fortified Lab Threshed Teff (FTT)
The intervention will take place for 7 months in Debre Zeit where this arm will be fed injera from teff that is threshed using a modern thresher. In addition, they will receive Ferrous sulfate drops

Locations

Country Name City State
Ethiopia Center for Food Science and Nutrition, Addis Ababa University Addis Ababa
Switzerland Swiss Federal Institute of Technology ETH Zurich Zurich

Sponsors (3)

Lead Sponsor Collaborator
Swiss Federal Institute of Technology Addis Ababa University, HarvestPlus

Countries where clinical trial is conducted

Ethiopia,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Haemoglobin Iron status Three collection points - First collection point at screening, second collection point at mid point (3.5 months after start of intervention) and third collection point at the end point ( end of the 7 months of the intervention)
Primary Change in Ferritin Iron status Two collection points - First collection point at screening, second collection point at the end of the study ( 7 months after the intervention start )
Primary Change in Soluble Transferrin Receptor (sTfR) Iron status Two collection points - First collection point at screening, second collection point at the end of the study ( 7 months after the intervention start )
Primary Change in C-Reactive Protein (CRP) Inflammation Two collection points - First collection point at screening, second collection point at the end of the study ( 7 months after the intervention start )
Primary Change in Alpha 1-Acid Glycoprotein (AGP) Inflammation Two collection points - First collection point at screening, second collection point at the end of the study ( 7 months after the intervention start )
Secondary Change in Aluminium (Al) levels Measuring Al in plasma Two collection points - First collection point at screening, second collection point at the end of the study ( 7 months after the intervention start )
Secondary Change in Aluminium (Al) levels Measuring Al in hair and nail Three collection points - First collection point at the first day of the study, Second collection point during mid point ( 3.5 months after start of the intervention, and third collection point at the end of the intervention ( end of 7th month)
Secondary Change in Anthropometric measurements Weight in kg Three collection points - First collection point during screening, Second collection point during mid point ( 3.5 months after start of the intervention, and third collection point at the end of the intervention ( end of 7th month)
Secondary Change in Anthropometric measurements Height in cm Three collection points - First collection point during screening, Second collection point during mid point ( 3.5 months after start of the intervention, and third collection point at the end of the intervention ( end of 7th month)
Secondary Teff flour Iron concentration Through study completion, an average of 7 months
Secondary Teff flour Phytate content Through study completion, an average of 7 months
Secondary Morbidity Any sickness arising due to the consumption of the meals Through study completion, an average of 7 months
Secondary Injera consumption Amount of injera consumed by the child in each meal Through study completion, an average of 7 months
Secondary 2 day weighted food record To estimate the amount of different foods consumed by the child Through study completion, an average of 7 months
See also
  Status Clinical Trial Phase
Recruiting NCT06027801 - Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity N/A
Completed NCT02282553 - Gastric Capsule Examination for Iron Deficiency Anaemia N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Phase 4
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01307007 - Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Phase 2
Completed NCT00982007 - Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Phase 3
Completed NCT00198848 - Iron Supplementation Among Adolescent Girls in India N/A
Completed NCT01166451 - The Anemia Control Program: High or Low Iron Supplementation N/A
Recruiting NCT03893045 - A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Phase 3
Recruiting NCT03817957 - Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency Phase 3
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Completed NCT03618914 - Anemia and Inflammation
Completed NCT03940430 - Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Phase 2/Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Completed NCT03237065 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department